AN
CelLBxHealth plc
ANPCY · OTC
$0.07 +0.00% (+$0.00)
Market Cap £1.63M
P/E Ratio -
Div. Yield -
ROE 104.73%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.62x
P/B 0.14x
P/E N/A
Growth
61 /100
Stable Rev. growth 6.10%
Book val. growth 14.63%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 62.27%
Net margin 601.37%
Op. margin 627.67%
Quality
2 /100
Poor ROIC 105.60%
ROE 104.73%
ROA 87.26%
Debt
80 /100
Low Debt/Equity 0.31x
Current ratio 3.13x
Int. coverage -38.21x
Stability
42 /100
Moderate Beta 0.14x
Rev. volatility 23.15%
EPS volatility 19.40%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ANPCY
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Peter Collins
Employees
119
Headquarters
Guildford